Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate Neuromuscular Blockade in Laparoscopic Gastrectomy
NCT03782233Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rocuronium in neuromuscular blockade (NMB) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Plasma Concentration of D-lactic Acid, Plasma Concentration of Diamine Oxidase (DAO) and 3 more. Started Jan 2019; status: completed.
02
Drugs
rocuronium
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03782233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03782233.